Pancreatic Cancer Epidermal Growth Factor Receptor (<Emphasis Type="Italic">EGFR</Emphasis>) Intron 1 Polymorphism Influences Postoperative Patient Survival and in vitro Erlotinib Response期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Pancreatic Cancer Epidermal Growth Factor Receptor (EGFR) Intron 1 Polymorphism Influences Postoperative Patient Survival and in vitro Erlotinib Response

Authors:	Ching-Wei D. Tzeng Andrey Frolov Natalya Frolova Nirag C. Jhala J. Harrison Howard Selwyn M. Vickers Donald J. Buchsbaum Martin J. Heslin J. Pablo Arnoletti

Affiliation:	(1) Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA;(2) Department of Pathology, University of Alabama of Birmingham, Birmingham, AL, USA;(3) Department of Surgery, University of Minnesota, Minneapolis, MN, USA;(4) Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA

Abstract:

Keywords:	EGFR Epidermal growth factor receptor Pancreatic cancer Intron 1 Polymorphism Erlotinib
本文献已被 PubMed SpringerLink 等数据库收录！